GLP-1 Agonists – Principles of Patient Care Management The webinar covered the essential role of GLP-1 receptor agonists (GLP-1 RAs) in obesity and metabolic health, their mechanisms of action, and the broader implications for patient care. It emphasized the need for a comprehensive obesity assessment beyond BMI, highlighting better measures such as waist-to-hip ratio (WHR) and fat mass index (FMI). Key prescribing principles were discussed, including indications, contraindications, dosing strategies, and co-management approaches to improve treatment efficacy and minimize side effects. The session also explored the integration of naturopathic and lifestyle interventions to enhance patient outcomes and manage the common side effects of GLP-1 RAs, such as nausea, constipation, and sarcopenia. The session concluded by reinforcing the importance of personalized and integrative patient care when using GLP-1 RAs, ensuring their use aligns with sustainable metabolic health improvements and long-term weight management strategies. Category A Credits Pending